Hematology TimesExpanded UCB product can stand aloneFebruary 27, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantationAMLALLMyelodysplastic Syndrome
Hematology TimesSurvival differences among AYAs with blood cancersJanuary 11, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLHodgkin LymphomaCMLNon-Hodgkin Lymphoma
Hematology TimesMarine animals aid development of cytotoxicity assayJanuary 11, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLCMLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology NewsFDA expands indication for bosutinib in newly diagnosed CMLJanuary 2, 2018CMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsFDA updates nilotinib product label outlining criteria for discontinuationDecember 27, 2017CMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesNilotinib label updated with info on discontinuationDecember 23, 2017Leukemia, Myelodysplasia, TransplantationPharmacyCML
Hematology TimesFDA expands approved use of bosutinib in CMLDecember 20, 2017Leukemia, Myelodysplasia, TransplantationPharmacyCML
Hematology TimesCompany launches digital PCR test for monitoring CMLDecember 7, 2017Leukemia, Myelodysplasia, TransplantationCML
Hematology TimesCompanies launch generic busulfan in USDecember 6, 2017Leukemia, Myelodysplasia, TransplantationPharmacyCML
Hematology TimesNilotinib approved to treat kids with CML in EUNovember 21, 2017Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyCML
Oncology PracticeCancer patients with TKI-induced hypothyroidism had better survival ratesNovember 15, 2017Patient & Survivor CareCMLGastroenterologyLeukemia, Myelodysplasia, TransplantationALLLung CancerRenal Cell Carcinoma
Hematology NewsFDA approves dasatinib for pediatric Ph+ CMLNovember 14, 2017CMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesDasatinib approved to treat kids with CMLNovember 11, 2017Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyCML
Hematology TimesNatural selection opportunities tied to cancer ratesOctober 13, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLHodgkin LymphomaCML
Hematology TimesNewer blood cancer drugs may not improve OS, QOLOctober 6, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLHodgkin LymphomaCMLNon-Hodgkin Lymphoma
